Dainippon Sumitomo Pharma Co Ltd, 10% Owner at Myovant Sciences Ltd. (MYOV), bought 140,000 shares at $11.00 ($1.5M) on 2020-04-14, disclosed to the SEC on 2020-04-15.
Open-market purchase of $1.5M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.81 | 70,000 | $687K | 47.1% |
| 2 | $11.00 | 70,000 | $770K | 52.9% |
| Total | $10.40 avg | 140,000 | $1.5M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-01 | $4.3M | — | Filing → |
| MYOV | BUY | 2021-08-20 | $2.7M | — | Filing → |
| MYOV | BUY | 2021-08-18 | $3.0M | — | Filing → |